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Abstract: The inclusion of a read-out to detect functional consequences of craniofacial alterations 9 
in the zebrafish embryotoxicity test will allow to evaluate these alterations which are difficult to 10 
assess morphologically, and to detect alterations in cranial nerves functions leading to impairment 11 
of jaw movements. In this study we have established an ingestion test in zebrafish larvae younger 12 
than 120 hpf.1To overcome the challenge of evaluating larvae which still do not present independent 13 
feeding behaviour, we have tested the ability of 72, 96 or 102 hpf larvae to ingest food mixed with 14 
fluorescent microspheres under several conditions (dark/light, with/without shaking) to find the best 15 
experimental set-up for the test. We have included the investigation of two substances as potential 16 
positive controls: ketoconazole and tricaine. Ketoconazole 10 µM exposure during development 17 
produced significant embryotoxic effects including a characteristic craniofacial alteration pattern 18 
consisting in impaired development of brain, nasal cavity, mouth opening and jaw, as well as a 19 
significant decrease in food intake. Tricaine exposure at 380 µM during the food availability period 20 
significantly decreased the food intake. The method proposed will be a useful alternative tool to 21 
animal testing to detect compounds inducing adverse effects on craniofacial development.  22 
Keywords: alternative methods; feeding; swallowing; jaw; cleft-palate; ingestion;   23 
 24 
 25 
                                                          
1 hpf: hours post fertilization; EW: OECD water; SC: solvent control; SEM: standard error of the mean. 
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1. Introduction 26 
Craniofacial malformations are one of the most common congenital defects, being orofacial clefts 27 
the most frequent (Lowry, 1985; Martínez-Frías et al., 2010; Parker et al., 2010). The causes of these 28 
malformations, either isolated or syndromic, are mostly unknown (Martínez-Frías et al., 2010), 29 
therefore more research is needed to be able to prevent them. An alternative method to animal 30 
experimentation to easily screen for craniofacial malformations would be a valuable tool to reduce the 31 
costs, time and number of animals compared to the current in vivo testing strategies. However, the 32 
formation of the craniofacial area is such a complex process that most in vitro tests cannot represent 33 
it completely. 34 
To this moment, the best alternative methods to reproduce craniofacial adverse effects observed 35 
in vivo were those based on whole organism models: the whole rodent embryo culture and the 36 
zebrafish embryo test (de Jong et al., 2011). In these tests the evaluation was mainly morphological 37 
based on different scoring systems (Beekhuijzen et al., 2015; Brown and Fabro, 1981; Piersma et al., 38 
2004; Stephan, 1991; Van Maele-Fabry et al., 1990) and when more precision was needed a double 39 
staining of cartilage and bone was added to the zebrafish assay (Kimmel and Trammell, 1981; Walker 40 
and Kimmel, 2007). However, with these techniques it is difficult to assess how morphological 41 
alterations in early development relate to functional impairment. The assessment of functional 42 
impairment could aid in the interpretation of the results of these techniques, specially by clarifying the 43 
classification into variations or developmental toxicity, as in in vivo testing according to the OECD 44 
guideline 414 (OECD/OCDE, 2018, 2001). In the guideline, variations are defined as “structural 45 
changes considered to have little or no detrimental effect on the animal, may be transient and may 46 
occur relatively frequently in the control population” (OECD/OCDE, 2018, 2001), while developmental 47 
toxicity includes major manifestations as “death of the organism, structural abnormality, altered 48 
growth, and functional deficiency” (OECD/OCDE, 2018, 2001). Based on these definitions, if a 49 
functional deficiency could be observed in zebrafish embryos/larvae it would be clearly classified as 50 
a developmental toxicity effect and could not be misplaced as a variation. As mentioned, craniofacial 51 
alterations found in zebrafish do not allow yet to distinguish functional deficiencies as those findings 52 
on toxicity testing of rats and rabbit do after decades of discussion (Solecki et al., 2003, 2001). 53 
However, the use of zebrafish embryos opens the door to evaluate the inability to ingest food and 54 
therefore add a functional endpoint to evaluate craniofacial alterations. 55 
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Although it has been described that zebrafish do not present independent feeding until 120 hours 56 
post fertilization (hpf) and that they still relay on the given yolk, their digestive system is completely 57 
formed 24 h before (Strähle et al., 2012). Because 120 hpf is the time when protected life stages in 58 
animal welfare regulations start, our aim was to establish an ingestion test in zebrafish larvae younger 59 
than 120 hpf to be used as an alternative model in developmental toxicity. For that purpose, we 60 
adapted a method previously applied to 7-9 days post fertilization (dpf) larvae which uses food mixed 61 
with fluorescent microspheres (Field et al., 2009). The intention of establishing such an endpoint was 62 
to have a functional read-out of a complex behavior which includes identification of the food (visually 63 
or using chemosensation), capturing the food (opening and closing the mouth), and ingesting 64 
(swallowing) (Kalueff et al., 2013). This evaluation would be very useful to i) check if craniofacial 65 
morphological alterations have functional consequences, ii) evaluate in a more objective way 66 
craniofacial alterations which are difficult to score morphologically, iii) detect alterations in cranial 67 
nerves, which lead to impairment of jaw movements but with no musculoskeletal morphological effect.  68 
To overcome the challenge of using larvae which still do not present independent feeding 69 
behaviour, we have tested several conditions (dark/light, with/without shaking) in larvae of 72, 96 or 70 
102 hpf to find the best experimental set-up to evaluate ingestion ability during these developmental 71 
stages. Besides, we have investigated two chemicals which are likely to affect ingestion of the 72 
zebrafish larvae by different mechanisms; ketoconazole most likely to interfere through craniofacial 73 
morphological alterations (Amaral and Nunes, 2008; Menegola et al., 2006; Nishikawa et al., 1984) 74 
and tricaine by suppressing movements needed for intake by blocking neuromuscular transmission 75 
(Attili and Hughes, 2014; Hedrick and Winmill, 2003; Zahl et al., 2012). 76 
2. Materials and Methods  77 
The determination of the concentration-effect relationship of ketoconazole on morphological 78 
endpoints and the implementation of functional endpoints in the zebrafish embryo assay were 79 
performed in two different facilities. The differences in the protocols were confirmed to have no impact 80 
on the comparability of results in both laboratories. 81 
2.1. Adult zebrafish maintenance and egg production 82 
In the laboratory at the University of Barcelona (laboratory A), maintenance of the adult colony 83 
of zebrafish was approved by the Ethics Committee for Animal Experimentation of the University of 84 
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Barcelona (CEEA), accepted by the Department of Environment and Housing of the Generalitat de 85 
Catalunya with the license number 334/18, and according to the Generalitat de Catalunya Decree 86 
214/1997 of 30th of July, which regulates the use of animals for experimental and other scientific 87 
purposes. Adult zebrafish (Danio rerio) from BCN Piscicultra Iberica; Terrassa, Spain, were kept in 88 
tanks with a closed flow-through system in OECD water as specified in ISO 7346-1 and 7346-2 (ISO, 89 
1996; 2 mM CaCl2·2H2O; 0.5 mM MgSO4 ·7H2O; 0.75 mM NaHCO3; 0.07 mM KCl). Animals were 90 
maintained at 26 ± 1 ºC on a 14 hours light and 10 hours dark cycle and were fed two times a day, 91 
once with brine shrimp and once with dry flake food. The day before the test, adult male and female 92 
were transferred to breeding tanks. Spawning was triggered once the light was turned on. Eggs 93 
harvested between 1 and 2 hours after spawning were collected, cleaned with OECD water diluted 94 
1:5 and selected under a dissection stereomicroscope. 95 
In the laboratories at the BASF SE (laboratory B) maintenance of the adult colony was approved 96 
by an AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care 97 
International) certified laboratory. In-house bred wild type fish were kept in tanks with a single pass 98 
flow-through system in OECD water. Animals were maintained at 26 ± 1 ºC on a 16 hours light and 8 99 
hours dark cycle and were fed two times a day, once with brine shrimp and once with dry flake food. 100 
The day before the test, adult male and female were transferred to breeding tanks in pairs. Eggs 101 
harvested between 1 and 2 hours after spawning were collected, cleaned with undiluted OECD water 102 
and selected under a dissection microscope. 103 
2.2. Zebrafish embryo assay conditions 104 
Only fertilized eggs demonstrating homogenous synchronous development (between 16- and 105 
256-cell stage) were selected. 106 
 In the laboratory at the University of Barcelona (laboratory A) they were randomly distributed 107 
into 6-well plates (10 embryos/well), water was replaced by 5 mL of Danieau’s solution 0.3X (17.4 108 
mM NaCl; 0.23 mM KCl; 0.12 mM MgSO4 ·7H2O; 0.18 mM Ca(NO3)2; 1.5 mM HEPES; pH 7,4) and 109 
plates were incubated at 26 ± 1 ºC. Danieau’s solution was replaced (10 mL) after 24 h. In 110 
experiments with ketoconazole (Santa Cruz Biotechnology; ≥99% purity; CAS-No. 65277-42-1), wells 111 
were saturated with test solutions for 24 h prior to the start of the experiment, and test solutions were 112 
freshly prepared and replaced at 0 hpf and 24 hpf. 6-well plates were filled with 5, 5, and 10 ml 113 
solutions at -24, 0, and 24 hours, respectively. 114 
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 In the laboratories at the BASF SE (laboratory B) eggs were randomly distributed in 24-well 115 
plates (1 embryo/well), water was replaced by 1 ml of OECD water, and replaced (1 ml) after 24 h. In 116 
experiments with ketoconazole (Sigma-Aldrich; ≥99% purity; CAS-No. 65277-42-1), wells were 117 
saturated with test solutions for 24 h prior to the start of the experiment, and test solutions were freshly 118 
prepared and replaced at 0 hpf and 24 hpf. 24-well plates were filled with 1 ml at the same time points 119 
of culture. 120 
For the determination of concentration-effect relationship of ketoconazole in the concentration 121 
range from 0.1 to 33 µM in laboratory B three independent experiments aiming to use 12 embryos 122 
per test group (finally resulting in sample size of 9 to 12 embryos per test group depending on 123 
availability of suitable eggs) were performed. Two control groups were included each time 1) OECD 124 
water (embryonic water - EW) and 2) vehicle control (0.5% DMSO, solvent control - SC). 125 
Morphological evaluation of the embryos was performed at 120 hpf under a dissection microscope 126 
using a morphological score with 39 parameters (Supplementary Table 1) including two criteria for 127 
mortality (coagulation and/or heartbeat arrest), 13 parameters for general embryotoxicity and 24 128 
parameters for specific embryotoxicity (Flick et al., 2017). For the evaluation the zebrafish were in 129 
tricaine narcosis. 130 
2.3. Fluorescent tracer 131 
The fluorescent tracer was prepared as described in Field et al., (2009). Briefly, 100 mg of 132 
powdered larval feed (Zebrafeed by Sparos <100 µm) were mixed on a watch glass with 150 µL of 133 
yellow-green 2 μm fluorescent polystyrene microspheres (Invitrogen by Termo Fisher Scientific, 134 
FluoSpheres TM carboxylate, 2.0 μm, yellow-green (505/515), Ref. F8827) and 50 µL of deionized 135 
water. Ingredients were stirred until a paste was formed and it was spread as a thin layer. The mixture 136 
was left overnight in the dark at room temperature to dry, and then was scraped from the glass and 137 
grinded between two pieces of weighing paper to powder. The fluorescent tracer was stored in a 138 
glass recipient at room temperature protected from the light.  139 
2.4. Food administration 140 
At 72 hpf, 96 hpf or 102 hpf, approximately 2 mg of tracer was added to each well of a 6-well 141 
plate. The larvae were left at 26 ± 1 ºC in the constant-temperature room with the tracer for 3 h. 142 
Depending on the testing conditions (A to F) plates were stirred every 30 minutes (160-170 rpm, 10 143 
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s). After these 3 h, medium with tracer was removed and replaced with 5 ml of Danieau’s solution 144 
0.3X. Afterwards, larvae were transferred to a new well of another 6-well plate with new Danieau’s 145 
0.3X (5 mL). Larvae were placed individually on wells of 24-well plates and anesthetized by adding 146 
650 µL tricaine 0.1% (ethyl 3-aminobenzoate methanesulfonate salt, by Sigma Aldrich, ≥98 % purity, 147 
CAS-No. 886-86-2) per well. Larvae were analyzed using an inverted fluorescent microscope (Nikon 148 
eclipse TS100) for presence/absence of fluorescence in the gastrointestinal tract (no quantification of 149 
the amount ingested was intended). It was easily distinguishable the background fluorescence of the 150 
yolk (see picture of condition A in Figure 1) from the food fluorescence in the gastrointestinal track 151 
(see picture of conditions C and E in Figure 1). Pictures of representative larvae were taken from 152 
different body parts using the same conditions for fluorescent channel exposure (200 ms) and 153 
subsequently joining together the fragments with Adobe Photoshop CC®.  154 
Tricaine (also known as 3-aminobenzoic acid ethyl ester or MS-222), the general anaesthetic 155 
used in fishes to suppress movement (Attili and Hughes, 2014; Hedrick and Winmill, 2003; Zahl et 156 
al., 2012), was selected as a compound to affect the ‘food ingestion’ endpoint. The conditions for this 157 
experimental group were established as follows: zebrafish embryos were grown under control 158 
conditions until 102 hpf. Fifteen minutes before adding the fluorescent food, medium was replaced 159 
by tricaine 380 µM in Danieau’s solution 0.3X. Fluorescent food was then added to the wells for 3 h 160 
under light and shaking conditions.  161 
2.5. Statistics 162 
Statistical analysis was performed with GraphPad Prism software v7. Statistical comparisons 163 
were made with two-tailed t-test, Fisher’s exact test or one-way ANOVA as indicated in each graph 164 
or table. Significance threshold was established at p≤0.05. 165 
3. Results 166 
3.1. Establishment of experimental conditions 167 
To establish the feeding test in larvae under 120 hpf, several conditions were tested. Starting 168 
conditions were based on a previous publication of Field et al., (2009), where 7 dpf larvae were fed 169 
food mixed with fluorescent microspheres, but some adaptations were made: only larvae between 3 170 
and 4.5 dpf were used, food availability period was extended from 2 to 3 hours, larvae were visualized 171 
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immediately after removing the food instead of waiting 3, 6, 12 or 24 h, and light/dark and/or shaking 172 
conditions were applied during the feeding time. 173 
Zebrafish larvae open the mouth first at 72 hpf (Kimmel et al., 1995), so this was the point chosen 174 
for the initial test condition (A). However, at this early developmental stage almost no larvae ingested 175 
food (Figure 1, condition A; mean ± SEM= 3% ± 3). As liver, pancreas and gut are formed at 76 hpf 176 
and anus opens at 96 hpf (Field et al., 2003a, 2003b; Strähle et al., 2012), we waited until the whole 177 
digestive system was formed (96 hpf) for condition B. At this point, approximately 50% of larvae were 178 
ingesting fluorescent food (mean ± SEM= 48% ± 11) which represented a significant increase from 179 
condition A. Considering that larvae at these stages are mainly inactive and they only start to actively 180 
swim freely after 120 hpf (Strähle et al., 2012), and also that in locomotion tests, darkness is described 181 
to increase locomotion (MacPhail et al., 2009; McDougall et al., 2016), we introduced two 182 
modifications to the protocol: shaking of plates every 30 minutes (C and D) and/or feeding under dark 183 
conditions (D). Besides, the number of larvae tested per group was increased from 10 to 20. The 184 
inclusion of shaking every 30 minutes significantly increased the percentage of larvae ingesting 185 
compared to condition B, but only under light conditions (Figure 1, condition C; mean ± SEM= 76% ± 186 
5). To finally check if the conditions could still be improved without exceeding the 120 hpf, we tested 187 
the ingestion of 102 hpf larvae, again under light and dark conditions, and including shaking in both 188 
cases. At 102 hpf under light and shaking conditions the highest percentage with the lowest SEM was 189 
obtained (mean ± SEM= 89% ± 0.3). At this time-point, again, the percentage of larvae ingesting was 190 
lower under dark conditions. In view of these results, condition E was selected for further experiments. 191 
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 192 
Figure 1. Summary of timelines of the six different experimental conditions assayed to establish the 193 
ingestion test. Shaking of 6-well plates every 30 minutes is indicated with circular arrows. Graph 194 
represents the percentage of larvae with fluorescence in the gastrointestinal tract for all conditions 195 
tested. Results presented as mean ± SEM of at least three independent experiments with 10 (A and 196 
B) or 20 (C to F) larvae per group and experiment. *: p ≤ 0.05 versus the group indicated in letters 197 
underneath by ANOVA and Holm-Sidak test. Representative pictures of a larvae from each age 198 
tested: A (72 hpf) showing no fluorescence; C (96 hpf) showing fluorescence in the oesophagus and 199 
the stomach; and E (102 hpf) with fluorescence in the stomach, intestine and outside the cloaca. 200 
3.2. Establishment of positive controls 201 
Following the recommendations for developing alternative methods for the screening and 202 
prioritization of chemicals (Crofton and Mundy, 2011), two substances considered as potential 203 
positive controls of the test. Two positive controls reliably and consistently altering the end-point by 204 
two different known mechanisms were established.  205 
3.2.1. Induction of craniofacial malformations with ketoconazole. 206 
Ketoconazole was selected as potential endpoint-specific control for the induction of craniofacial 207 
alterations because this azole-derivative is known to induce craniofacial malformations in rats in vivo, 208 
including induction of cleft palate (Amaral and Nunes, 2008; Nishikawa et al., 1984) and in rat 209 
embryos in vitro, including abnormalities in branchial arches (Menegola et al., 2006). 210 
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A broad concentration range study was conducted in the laboratories at the BASF SE (laboratory 211 
B) to evaluate developmental toxicity of ketoconazole in zebrafish embryos. At 120 hpf there was no 212 
mortality or alterations higher than 10% in any parameter of the morphological score in any control 213 
group (control and solvent control) demonstrating the validity of the three performed experiments. 214 
After exposure to increasing concentrations of ketoconazole between 0.1 and 3 µM the results were 215 
comparable to the solvent control in mortality and general as well as specific embryotoxicity. At 10 216 
µM the incidence of mortality was still comparable to controls, but the percentages of general and 217 
specific embryotoxicity were significantly increased (mean ± SEM= 97.3% ± 2.7 and 58.3% ± 29.3, 218 
respectively; Figure 2). As ketoconazole exposure at 33 µM was lethal to all embryos in all 219 
experiments, no further assessment of morphological alterations at this concentration is given. 220 
Summarizing these results of laboratory B, 10 µM exposure represents the lowest observed adverse 221 
effect concentration (LOAEC) of ketoconazole based on the findings in the morphological score for 222 




Figure 2. Graph summarizing the percentages of larvae presenting: specific embryotoxicity (green), 227 
general embryotoxicity (gray) and mortality (black) as mean ± SEM of three independent experiments 228 
performed in laboratory B for increasing concentrations of ketoconazole. Statistical analysis 229 
performed with one-way ANOVA and statistical significance (*) defined as p ≤0.05 versus solvent 230 
control. EW: embryo water; SC: solvent control (0.5% DMSO). Representative pictures of 120 hpf 231 
larvae from solvent control, 1, 3 and 10 µM groups, with magnification of the craniofacial area of the 232 
same larvae, and black arrows indicating the specific embryotoxic effects detected in the craniofacial 233 
area. 234 
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Looking in detail at the individual parameters of the morphological score (Table 1) representing 235 
general embryotoxicity, a significant increase in pericard oedema was found at 3.3 µM. However, this 236 
finding was not observed at 10 µM and there was no concentration-dependency, so it was considered 237 
to be spontaneous and not related to the treatment. The 10 µM concentration, significantly increased 238 
parameters related with general embryotoxicity like yolk sac still present and overall degeneration. 239 
For those parameters related with specific embryotoxicity, at 3.3 µM four out of 24 parameters were 240 
slightly increased, but since the incidences were below or only slightly above 10%, and were not 241 
significant, these findings were considered spontaneous and comparable to the controls. At 10 µM, 242 
however, the same four parameters: brain impairment, nasal cavity impairment, mouth opening 243 
impairment and jaw impairment were all significantly increased. The combination of these 244 
manifestations represents a pattern of craniofacial alteration in the zebrafish. Since the increase in 245 
the other 20 of 24 parameters for specific embryotoxicity was not significant (very low percentages), 246 
it was concluded that this craniofacial altered pattern is characteristic for ketoconazole in the zebrafish 247 






morphological    Ketoconazole [µM]  
 score EW SC 0.1  0.3  1  3.3  10  33  
                    
Mortality coagulated 0% 0% 0% 6% 6% 3% 8% 100%* 
General          




0% 0% 0% 0% 0% 0% 33%*  




0% 0% 3% 0% 0% 18%* 0%  









0% 3% 0% 0% 0% 9% 39%*  





0% 3% 0% 0% 0% 6% 39%*  
 jaw impairment 0% 3% 0% 0% 0% 9% 58%*  
Table 1. Summary of the percentages of larvae per test group with alterations (expressed as 251 
frequencies) corresponding to each parameter evaluated in the morphological score and classified as 252 
mortality, general embryotoxicity or specific craniofacial toxicity. Results obtained in laboratory B. 253 
Statistical analysis performed with Fisher’s exact test and statistical significance (*) defined as p≤0.05 254 
versus solvent control. EW: embryo water; SC: solvent control (0.5% DMSO). 255 
 256 
From these results, the 10 µM concentration was preliminarily selected to be tested in laboratory 257 
A (University of Barcelona) as a potential positive control for the ingestion test. A first range finding 258 
experiment with four concentrations of ketoconazole (1, 5, 10 and 20 µM) was performed to test the 259 
inter-laboratory reproducibility of the effective concentrations (Supplementary Table 2). After 72h of 260 
exposure, at 20 µM of ketoconazole 100% of mortality was found while at 5 µM no craniofacial 261 
adverse effects were observed (n=1). Therefore, the 10 µM concentration was finally selected and 262 
zebrafish embryos were grown under exposure to this concentration of ketoconazole until 102 hpf, 263 
when fluorescent food was added to the wells for 3 h under light and shaking conditions. As expected, 264 
10 µM ketoconazole exposure induced a significant increase in craniofacial alterations (mean ± SEM= 265 
40.7% ± 5.4) without significantly increasing mortality (mean ± SEM= 8.3% ± 3.3). Moreover, a 266 
significantly lower percentage of larvae with fluorescence presence in the gastrointestinal tract was 267 
observed at this concentration (Figure 3; mean ± SEM= 52.1% ± 13.5). 268 
3.2.2. Inhibition of neuromuscular transmission with tricaine. 269 
Tricaine exposure during the food availability time, completely reduced the number of larvae with 270 
fluorescence presence in the gastrointestinal tract (mean ± SEM= 1.7% ± 1.7; Figure 3). 271 
 272 
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 273 
Figure 3. Graph representing the percentage of larvae with fluorescence in the gastrointestinal tract 274 
for the solvent control and two tested substances: ketoconazole 10 µM and tricaine 380 µM. Results 275 
presented as mean ± SEM of three independent experiments with 20 larvae per group and 276 
experiment. *: p ≤ 0.05 versus control by two-tailed t-test. Representative pictures of a larvae from 277 
each condition tested: Solvent Control (0.1% DMSO) showing fluorescence in the stomach and 278 
intestine; ketoconazole 10 µM with craniofacial alterations (black arrow) and no fluorescence; tricaine 279 
380 µM without food fluorescence in the gastrointestinal tract and showing the variability in natural 280 





4. Discussion 286 
This study presents the methodology to implement the functional endpoint ‘food ingestion’ to the 287 
zebrafish embryotoxicity test to add the final adverse outcome ‘food ingestion impairment’ to the 288 
evaluation of craniofacial abnormalities. It is important to remark that the endpoint is evaluated before 289 
120 hpf and can therefore be included as part of a battery of alternative tests to animal 290 
experimentation according to the animal welfare law in most regions. 291 
Previous evaluations on food intake behavior of zebrafish larvae already determined that they 292 
are not able to feed independently until 120 hpf. Belanger et al., (2010) evaluated their intake abilities 293 
at 96 hpf and observed that 0% of larvae ingested food, while at 120 hpf 75 to 85% did. These findings 294 
could seem contradictory with our results at 96 hpf, but this is not strictly true, as several conditions 295 
were changed in order to increase the chances of food intake observation. While the study of Belanger 296 
et al., (2010) aimed at recreating conditions similar to the natural environment of zebrafish to assess 297 
the development of their feeding skills, our aim was to create an artificial situation favoring the 298 
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maximum food intake. In their study, food was available for only 1 h while in our protocol it was 299 
available for 3 h. Their food were fluorescent protozoa or protozoa mixed with fluorescent 300 
microspheres while ours was processed food with fluorescent microspheres. Maybe ingestion of alive 301 
and moving food requires more coordination of movements for pray tracking and capturing than non-302 
moving food. Besides, their embryos were grown at 25 ± 1 ºC and ours at 26 ± 1ºC which could 303 
explain a slightly faster development under our conditions. But the critical difference was the addition 304 
of shaking every 30 minutes during the 3 h of availability of food. The inclusion of this step in the 305 
methodology forced the larvae to swim and significantly increased the chances of food intake 306 
observation, while in other studies, larvae probably remained immobile during the short time of food 307 
exposure (Strähle et al., 2012). Our work shows that parameters like developmental stage, duration 308 
of food availability, kind of food, light intensity and forced swimming conditions have a clear influence 309 
on food intake behavior before 120 hpf. It is important to remark that none of the conditions tested 310 
achieved a 100% of larvae ingesting food in any of the experiments, indicating that at the tested time-311 
points, even under the most favorable conditions, not all larvae have developed the ability to ingest 312 
food. Although the yolk of the zebrafish embryos was significantly decreased during the culture, it 313 
was still present at 102 hpf ensuring the nutrition supply. 314 
From all the conditions tested in this study, 102 hpf was selected as the best time-point to perform 315 
the test because it had the highest percentage of larvae ingesting food and the lowest variability 316 
among experiments. However, depending on the desired dynamic range of the test, e.g. to detect an 317 
increase in the % of larvae ingesting food after developmental exposure to a compound, 96 hpf could 318 
also be a valid time-point. The disadvantage of the 96 hpf time-point is a high variability among 319 
different experiments that could fail to detect small increases/decreases in the percentage of larvae 320 
ingesting food or to identify the effects of compounds which induce alterations with high variability in 321 
results too. 322 
To prove that following the proposed methodology it is possible to detect decreases in the 323 
evaluated endpoint, we investigated two chemicals acting by different mechanisms. The first 324 
substance tested was ketoconazole, an azole-derivative that induces craniofacial malformations in 325 
rats in vivo (Amaral and Nunes, 2008; Nishikawa et al., 1984) and in vitro in the post-implantation 326 
whole embryo culture (Menegola et al., 2006). Our evaluation of the adverse effects of ketoconazole 327 
detected a characteristic pattern of craniofacial malformations at 10 μM consisting in alterations of 328 
brain, nasal cavity, mouth opening and jaw. In previous studies in rat embryos, the NOAEL was 329 
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established at 5 µM, the first significant increase in the percentage of malformed embryos was 330 
detected at 10 µM and approximately 70% of embryos presented branchial arch malformations at 50 331 
µM (Menegola et al., 2006). Therefore, it can be concluded that ketoconazole produces craniofacial 332 
adverse effects in a similar concentration range in zebrafish and in rat embryos in vitro. To the best 333 
of our knowledge, this is the first time that craniofacial adverse effects of ketoconazole have been 334 
reproduced in zebrafish embryos. Ketoconazole was previously investigated using zebrafish in the 335 
US EPA ToxCast program (Truong et al., 2014). However, in this screening program, which includes 336 
more than 1000 compounds, no detailed concentration ranges of effective concentrations could be 337 
investigated for all test compounds to identify the specific morphological pattern detectable around 338 
the LOAEC for each test substance. The investigated concentration range by ToxCast (0.064 - 64 339 
µM overlaps with our concentration range tested (0.1 – 33 µM) but our smaller dilution factor of 3 340 
instead of 10 offered a more precise detection of the LOAEC. 341 
The characterization of the developmental adverse effects of ketoconazole in zebrafish has been 342 
performed in a different lab than the food intake assessment. However, the concentration-effect 343 
relationship determined for ketoconazole in both laboratories was comparable demonstrating the 344 
robustness of the zebrafish embryo assay. The differences in the protocol, mentioned in material and 345 
methods, including different zebrafish strains, culture vessels, light/dark periods, mating procedure, 346 
etc., did not bias the comparability of results in case of ketoconazole testing. 347 
Food intake in embryos developmentally exposed to ketoconazole 10 µM was significantly 348 
decreased compared to solvent control (mean ± SEM= 52.1% ± 13.5). Although at 10 µM exposure 349 
general embryotoxicity was also observed in 97% of embryos (Figure 2, gray line), still approximately 350 
50% of them were ingesting food which indicates that, in this particular case, this general 351 
embryotoxicity was not an impairment for food ingestion. This is important, as the aim of the test is to 352 
detect functional consequences of specific craniofacial adverse effects. A limitation of the test is that 353 
in case of severe general retardation of development in the embryos, a decrease in the percentage 354 
of larvae ingesting food would be expected. It is therefore strongly recommended to register general 355 
parameters of development like yolk sac size to detect general embryotoxicity (Supplementary Table 356 
1) to improve the selectivity of the endpoint. Nevertheless, small retardations do not suppose an 357 
impairment for feeding under the conditions established, as already shown in this study. Accordingly 358 
to this evaluation, ketoconazole 10 µM exposure during development was selected as positive control 359 
for the test. 360 
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The second test substance selected was tricaine at concentration 380 µM. In this case, there 361 
was no developmental exposure to the compound, but just exposure from 15 minutes before and 362 
during the 3 h of food availability. The percentage of larvae ingesting food was significantly decreased. 363 
This shows that the endpoint is not only altered when embryos have craniofacial malformations, but 364 
also when zebrafishes cannot coordinate craniofacial movements. This condition was therefore 365 
selected as a suitable positive control to inhibit the active and coordinated facial movements needed 366 
for ingestion, e.g. moving the jaw to open and close the mouth or swallowing. As an active behavior 367 
is required for feeding, the test could also be used in the future to evaluate developmental 368 
neurotoxicity, as changes in feeding behavior can reflect changes in swimming/lethargy status as well 369 
as problems in more refined coordination. 370 
Considering all results presented, we can confirm that the method proposed enables the 371 
implementation of the assessment of the adverse outcome “impaired food intake ability” in zebrafish 372 
larvae younger than 120 hpf. This new end-point will be a useful alternative tool to animal testing to 373 
detect compounds inducing adverse effects on craniofacial development. 374 
Acknowledgments: This research work was supported by funds from Fundació Bosch i Gimpera, project 375 
number FBG-300155. We thank Martí Ducable, Laura Castro and the staff of the zebrafish facility (CCiTUB) for 376 
their excellent technical support and Lydia Camps for valuable manuscript revision. 377 
 378 
References 379 
Amaral, V.C.D.S., Nunes, G.P., 2008. Ketoconazole- and fluconazole-induced embryotoxicity and skeletal 380 
anomalies in Wistar rats: A comparative study. Brazilian Arch. Biol. Technol. 51, 1153–1161. 381 
https://doi.org/10.1590/S1516-89132008000600010 382 
Attili, S., Hughes, S.M., 2014. Anaesthetic tricaine acts preferentially on neural voltage-gated sodium channels 383 
and fails to block directly evoked muscle contraction. PLoS One 9. 384 
https://doi.org/10.1371/journal.pone.0103751 385 
Beekhuijzen, M., de Koning, C., Flores-Guill??n, M.E., de Vries-Buitenweg, S., Tobor-Kaplon, M., van de 386 
Waart, B., Emmen, H., 2015. From cutting edge to guideline: A first step in harmonization of the 387 
 16 of 20 
 
zebrafish embryotoxicity test (ZET) by describing the most optimal test conditions and morphology 388 
scoring system. Reprod. Toxicol. https://doi.org/10.1016/j.reprotox.2015.06.050 389 
Belanger, S.E., Balon, E.K., Rawlings, J.M., 2010. Saltatory ontogeny of fishes and sensitive early life stages 390 
for ecotoxicology tests. Aquat. Toxicol. 97, 88–95. https://doi.org/10.1016/j.aquatox.2009.11.020 391 
Brown, N.A., Fabro, S., 1981. Quantitation of rat embryonic development in vitro: a morphological scoring 392 
system. Teratology 24, 65–78. https://doi.org/10.1002/tera.1420240108 393 
Crofton, K., Mundy, W., 2011. Developmental neurotoxicity testing: recommendations for developing 394 
alternative methods for the screening and prioritization of chemicals. ALTEX 28, 9–15. 395 
https://doi.org/10.14573/altex.2011.1.009 396 
de Jong, E., Barenys, M., Hermsen, S.A.B., Verhoef, A., Ossendorp, B.C., Bessems, J.G.M., Piersma, A.H., 397 
2011. Comparison of the mouse Embryonic Stem cell Test, the rat Whole Embryo Culture and the 398 
Zebrafish Embryotoxicity Test as alternative methods for developmental toxicity testing of six 1,2,4-399 
triazoles. Toxicol. Appl. Pharmacol. 253, 103–111. https://doi.org/10.1016/j.taap.2011.03.014 400 
Field, H.A., Kelley, K.A., Martell, L., Goldstein, A.M., Serluca, F.C., 2009. Analysis of gastrointestinal 401 
physiology using a novel intestinal transit assay in zebrafish. Neurogastroenterol. Motil. 21, 304–312. 402 
https://doi.org/10.1111/j.1365-2982.2008.01234.x 403 
Field, H.A., Ober, E.A., Roeser, T., Stainier, D.Y.R., 2003a. Formation of the digestive system in zebrafish. I. 404 
Liver morphogenesis. Dev. Biol. 253, 279–290. https://doi.org/10.1016/S0012-1606(02)00017-9 405 
Field, H.A., Si Dong, P.D., Beis, D., Stainier, D.Y.R., 2003b. Formation of the digestive system in zebrafish. II. 406 
Pancreas morphogenesis. Dev. Biol. 261, 197–208. https://doi.org/10.1016/S0012-1606(03)00308-7 407 
Flick, B., Salinas, E.R., Birk, B., Otte, J., Ramirez, T., Hidding, B., Landsiedel, R., van Ravenzwaay, B., 2017. 408 
How to use the endpoints of a zebrafish embryotoxicity assay?, in: German Pharm-Tox Summit 2017. 409 
 17 of 20 
 
Hedrick, M.S.M.S., Winmill, R.E.R.E., 2003. Excitatory and inhibitory effects of tricaine (MS-222) on fictive 410 
breathing in isolated bullfrog brain stem. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R405-12. 411 
https://doi.org/10.1152/ajpregu.00418.2002 412 
Kalueff, A. V., Gebhardt, M., Stewart, A.M., Cachat, J.M., Brimmer, M., Chawla, J.S., Craddock, C., Kyzar, 413 
E.J., Roth, A., Landsman, S., Gaikwad, S., Robinson, K., Baatrup, E., Tierney, K., Shamchuk, A., Norton, 414 
W., Miller, N., Nicolson, T., Braubach, O., Gilman, C.P., Pittman, J., Rosemberg, D.B., Gerlai, R., 415 
Echevarria, D., Lamb, E., Neuhauss, S.C.F., Weng, W., Bally-Cuif, L., Schneider, and the Zebrafish 416 
Neuros, H., 2013. Towards a Comprehensive Catalog of Zebrafish Behavior 1.0 and Beyond. Zebrafish 417 
10, 70–86. https://doi.org/10.1089/zeb.2012.0861 418 
Kimmel, C.A., Trammell, C., 1981. A rapid procedure for routine double staining of cartilage and bone in fetal 419 
and  adult animals. Stain Technol. 56, 271–273. 420 
Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., Schilling, T.F., 1995. Stages of embryonic 421 
development of the zebrafish. Dev. Dyn. https://doi.org/10.1002/aja.1002030302 422 
Lowry, R.B., 1985. Common Congenital Anomalies. Can. Fam. Physician 31, 1033–1037. 423 
MacPhail, R.C., Brooks, J., Hunter, D.L., Padnos, B., Irons, T.D., Padilla, S., 2009. Locomotion in larval 424 
zebrafish: Influence of time of day, lighting and ethanol. Neurotoxicology 30, 52–58. 425 
https://doi.org/10.1016/j.neuro.2008.09.011 426 
Martínez-Frías, M.L., Bermejo, E., Cuevas, L., Periférico Del Ecemc, G., 2010. ANÁLISIS CLÍNICO-427 
EPIDEMOLÓGICO DE LOS RECIÉN NACIDOS CON DEFECTOS CONGÉNITOS REGISTRADOS EN 428 
EL ECEMC: DISTRIBUCIÓN POR ETIOLOGÍA Y POR GRUPOS ÉTNICOS. Boletín del ECEMC 9, 20–429 
41. 430 
McDougall, M.Q., Choi, J., Stevens, J.F., Truong, L., Tanguay, R.L., Traber, M.G., 2016. Lipidomics and 431 
 18 of 20 
 
H2(18)O labeling techniques reveal increased remodeling of  DHA-containing membrane phospholipids 432 
associated with abnormal locomotor responses in α-tocopherol deficient zebrafish (danio rerio) embryos. 433 
Redox Biol. 8, 165–174. https://doi.org/10.1016/j.redox.2016.01.004 434 
Menegola, E., Broccia, M.L., Renzo, F.D., Giavini, E., 2006. Dysmorphogenic effects of some fungicides 435 
derived from the imidazole on rat embryos cultured in vitro. Reprod. Toxicol. 436 
https://doi.org/10.1016/j.reprotox.2005.07.008 437 
Nishikawa, S., Hara, T., Miyazaki, H., Ohguro, Y., 1984. Reproduction studies of KW-1414 in rats and rabbits. 438 
Clin Rep. 18, 1433–88. 439 
OECD/OCDE, 2018. OECD/OCDE 414: OECD guideline for the testing of chemicals: Prenatal developmental 440 
toxicity study 1–14. 441 
OECD/OCDE, 2001. OECD guideline for the testing of chemicals: proposal for updating guideline 414. Guidel. 442 
Test. Chem. 1–13. https://doi.org/10.1787/9789264067394-eng 443 
Parker, S.E., Mai, C.T., Canfield, M.A., Rickard, R., Wang, Y., Meyer, R.E., Anderson, P., Mason, C.A., Collins, 444 
J.S., Kirby, R.S., Correa, A., 2010. Updated national birth prevalence estimates for selected birth defects 445 
in the United States, 2004-2006. Birth Defects Res. Part A - Clin. Mol. Teratol. 88, 1008–1016. 446 
https://doi.org/10.1002/bdra.20735 447 
Piersma, A.H., Genschow, E., Verhoef, A., Spanjersberg, M.Q.I., Brown, N.A., Brady, M., Burns, A., Clemann, 448 
N., Seiler, A., Spielmann, H., 2004. Validation of the postimplantation rat whole-embryo culture test in the 449 
international ECVAM validation study on three in vitro embryotoxicity tests. Altern. Lab. Anim. 32, 275–450 
307. 451 
Solecki, R., Bergmann, B., Burgin, H., Buschmann, J., Clark, R., Druga, A., Van Duijnhoven, E.A.J., Duverger, 452 
M., Edwards, J., Freudenberger, H., Guittin, P., Hakaite, P., Heinrich-Hirsch, B., Hellwig, J., Hofmann, T., 453 
 19 of 20 
 
Hubel, U., Khalil, S., Klaus, A. maria, Kudicke, S., Lingk, W., Meredith, T., Moxon, M., Muller, S., Paul, 454 
M., Paumgartten, F., Rohrdanz, E., Pfeil, R., Rauch-Ernst, M., Seed, J., Spezia, F., Vickers, C., Woelffel, 455 
B., Chahoud, I., 2003. Harmonization of rat fetal external and visceral terminology and classification.  456 
Report of the Fourth Workshop on the Terminology in Developmental Toxicology, Berlin, 18-20 April 457 
2002. Reprod. Toxicol. 458 
Solecki, R., Burgin, H., Buschmann, J., Clark, R., Duverger, M., Fialkowski, O., Guittin, P., Hazelden, K.P., 459 
Hellwig, J., Hoffmann, E., Hofmann, T., Hubel, U., Khalil, S., Lingk, W., Mantovani, A., Moxon, M., Muller, 460 
S., Parkinson, M., Paul, M., Paumgartten, F., Pfeil, R., Platzek, T., Rauch-Ernst, M., Scheevelenbos, A., 461 
Seed, J., Talsness, C.E., Yasuda, M., Younes, M., Chahoud, I., 2001. Harmonisation of rat fetal skeletal 462 
terminology and classification. Report of the Third Workshop on the Terminology in Developmental 463 
Toxicology. Berlin, 14-16 September 2000. Reprod. Toxicol. 464 
Stephan, K., 1991. Whole embryo culture: Interpretation of abnormal development in vitro. Reprod. Toxicol. 5, 465 
237–244. 466 
Strähle, U., Scholz, S., Geisler, R., Greiner, P., Hollert, H., Rastegar, S., Schumacher, A., Selderslaghs, I., 467 
Weiss, C., Witters, H., Braunbeck, T., 2012. Zebrafish embryos as an alternative to animal experiments-468 
A commentary on the definition of the onset of protected life stages in animal welfare regulations. 469 
Reprod. Toxicol. 33, 128–132. https://doi.org/10.1016/j.reprotox.2011.06.121 470 
Truong, L., Reif, D.M., St Mary, L., Geier, M.C., Truong, H.D., Tanguay, R.L., 2014. Multidimensional In Vivo 471 
Hazard Assessment Using Zebrafish. Toxicol. Sci. 137, 212–233. https://doi.org/10.1093/toxsci/kft235 472 
Van Maele-Fabry, G., Delhaise, F., Picard, J.J., 1990. Morphogenesis and quantification of the development of 473 
post-implantation mouse embryos. Toxicol. Vitr. 4, 149–156. 474 
Walker, M.B., Kimmel, C.B., 2007. A two-color acid-free cartilage and bone stain for zebrafish larvae. Biotech. 475 
 20 of 20 
 
Histochem. 82, 23–28. https://doi.org/10.1080/10520290701333558 476 
Zahl, I.H., Samuelsen, O., Kiessling, A., 2012. Anaesthesia of farmed fish: Implications for welfare. Fish 477 
Physiol. Biochem. 38, 201–218. https://doi.org/10.1007/s10695-011-9565-1 478 
 479 
